Pilot Study Could Improve Treatment of Chronic Diabetic Foot Ulcers
Summary: This pilot study evaluates a novel self-regulating hydrogel (GPP@ZnBG) for chronic diabetic foot ulcers. The hydrogel uses a pH-responsive mechanism: in the early alkaline inflammatory phase it releases zinc ions for antibacterial action, then degrades in the later healing phase to deliver zinc, calcium, and silicate ions that support angiogenesis and tissue regeneration. In the pilot, it achieved a 94.57% relative reduction in wound surface area within 4 weeks. The approach addresses key barriers in DFU healing (infection, inflammation, poor angiogenesis) more actively than conventional passive dressings. Results suggest potential for better outcomes and reduced amputation risk, with pharmacists playing a key role in adoption and patient education.
Key Highlights:
- Self-regulating pH-responsive zinc and bioactive ion release
- 94.57% relative wound area reduction in 4 weeks
- Targets infection, inflammation, and impaired angiogenesis
- Potential advancement over standard DFU dressings
Keywords: diabetic foot ulcers, GPP@ZnBG hydrogel, self regulating hydrogel, chronic DFU treatment